“It’s a big bet for the ten-year-old company, which currently has 24 products in its pipeline—but nothing yet on the market. The biotech sports a huge market cap of $17.5 billion, but it posted a net loss of $514 million on revenues of just $60 million last year. And most of that incoming cash came from government grants and research collaborations with big pharmaceutical companies.”
Moderna has never put a single product into the marketplace.
https://mail.google.com/mail/u/0/?pli=1#inbox/FMfcgxwHNVzNsxXbZttdpVvvtTbkGgrR
